Cargando…

Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study

BACKGROUND: The symptoms of early Parkinson's disease (PD) are complex and hidden. The aim of this study is to explore and summarize the characteristics of the symptoms of drug naïve patients with PD. OBJECTIVES: and Methods Drug-naïve patients with PD and age-matched healthy controls were recr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Weiqi, Wang, Yukai, Liu, Ling, Wu, Yi, Xu, Yu, Zhai, Heng, Yang, Xiaoman, Cao, Xuebing, Xu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362235/ https://www.ncbi.nlm.nih.gov/pubmed/37483764 http://dx.doi.org/10.1016/j.heliyon.2023.e18081

Ejemplares similares

Altered Intra- and Inter-Network Connectivity in Drug-Naïve Patients With Early Parkinson’s Disease
por: Zeng, Weiqi, et al.
Publicado: (2022)

Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
por: Zhai, Heng, et al.
Publicado: (2021)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
por: Jansen, Jamie A. F., et al.
Publicado: (2023)

Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by α–Syn and tau fragments
por: Yang, Xiaoman, et al.
Publicado: (2022)

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016)

Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
por: Fu, Rao, et al.
Publicado: (2016)

Evaluation of Wearable Sensor Devices in Parkinson's Disease: A Review of Current Status and Future Prospects
por: Lu, Ruirui, et al.
Publicado: (2020)

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

The Rodent Models of Dyskinesia and Their Behavioral Assessment
por: Peng, Qiwei, et al.
Publicado: (2019)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2021)

Dopaminergic Modulation of Biological Motion Perception in patients with Parkinson’s disease
por: Liu, Tingting, et al.
Publicado: (2017)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Dopaminergic Dysregulation, Artistic Expressiveness, and Parkinson's Disease
por: López-Pousa, S., et al.
Publicado: (2012)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Dopaminergic modulation of emotional conflict in Parkinson's disease
por: Fleury, Vanessa, et al.
Publicado: (2014)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Dopaminergic Modulation of Prospective Memory in Parkinson’s Disease
por: Costa, Alberto, et al.
Publicado: (2008)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
por: Kim, Ji Hwan, et al.
Publicado: (2023)

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
por: Tan, Yang, et al.
Publicado: (2020)

Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
por: Zhang, Xiaoqian, et al.
Publicado: (2021)

Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease
por: Wang, Bao-Yan, et al.
Publicado: (2021)

Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2022)

Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit
por: Zhao, Yadan, et al.
Publicado: (2021)

Sleep structure and related clinical characteristics in drug-naïve Parkinson's disease with subjectively different sleep quality
por: Jiang, Yinyin, et al.
Publicado: (2023)

Quantitative Electromyographic Analysis of Reaction Time to External Auditory Stimuli in Drug-Naïve Parkinson's Disease
por: Kwon, Do-Young, et al.
Publicado: (2014)

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review
por: Yang, Xiaoman, et al.
Publicado: (2023)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7gmg57gti0kjukf7tj8i7fqfi0